Local view for "http://purl.org/linkedpolitics/eu/plenary/2003-03-27-Speech-4-083"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20030327.3.4-083"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
".
I have welcomed and supported this outcome of the conciliation process. I fully subscribe to the determination to improve the protection of the health and safety of consumers, preventing, which is what this new directive does, substances classified as carcinogens, mutagens or substances toxic to reproduction and preparations containing these substances from being marketed for the use of the general public. In fact, as we know, ‘marketing’ implies greater responsibility for ensuring that the product in question will fulfil the purposes for which it is intended without compromising public health and safety (of persons and goods). This is a term that gives the general public the feeling that certain products are ‘trustworthy’. This trust must therefore be matched both by the provision for and listing of these products or substances – a measure proposed by the Commission, which I welcome – bearing in mind that the new EU strategy on chemical products will involve the registration of around 30 000 substances – and by a preliminary evaluation of the risks inherent in each substance. In fact, the monitoring, registration and handling of chemical products and substances must be covered by a set of rules that is clear, easy to understand and appropriate to the purposes for which the use of such products is intended."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples